✦ LIBER ✦

Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab

✍ Scribed by Park, Sung Chul; Su, Daniel; Tello, Celso

Book ID: 120356363
Publisher: Informa plc
Year: 2012
Tongue: English
Weight: 221 KB
Volume: 12
Category: Article
ISSN: 5847-4714
DOI: 10.1517/14712598.2012.721772

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical aspects of anti-VEGF agents

Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab

✍ Meyer, C H; Holz, F G 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 469 KB

A systematic review of the efficacy and

A systematic review of the efficacy and safety outcomes of anti-VEGF agents used for treating neovascular age-related macular degeneration: comparison of ranibizumab and bevacizumab

✍ Mitchell, Paul 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 259 KB

PSS11 Ranibizumab and Bevacizumab for th

PSS11 Ranibizumab and Bevacizumab for the Treatment of Age-related Macular Degeneration: A Systematic Review and Economic Evaluation

✍ Martinez Ferez, I.M.; Flores Moreno, S. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Predictive value of VEGF A and VEGFR2 po

Predictive value of VEGF A and VEGFR2 polymorphisms in the response to intravitreal ranibizumab treatment for wet AMD

✍ Cruz-Gonzalez, Fernando; Cabrillo-Estévez, Lucía; López-Valverde, Gloria; Cieza- 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 264 KB

Bevacizumab, a humanized anti-angiogenic

Bevacizumab, a humanized anti-angiogenic monoclonal antibody for the treatment of colorectal cancer

✍ I. Krämer; H.-P. Lipp 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Effects of Anti-VEGF Treatment Duration

Effects of Anti-VEGF Treatment Duration on Tumor Growth, Tumor Regrowth, and Treatment Efficacy

✍ Bagri, A.; Berry, L.; Gunter, B.; Singh, M.; Kasman, I.; Damico, L. A.; Xiang, H 📂 Article 📅 2010 🏛 American Association for Cancer Research 🌐 English ⚖ 737 KB